Intraocular and serum cytokine profiles in patients with intermediate uveitis

Molecular Vision

Volumn 17, Issue , 2011, Pages 2003-2010

  Valentincic, Natasa Vidovic ^a   de Groot Mijnes, Jolanda D F ^c   Kraut, Aleksandra ^a   Korosec, Peter ^b   Hawlina, Marko ^a   Rothova, Aniki ^c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b University Hospital for Pulmonary and Allergic Diseases   (Slovenia)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOPATHOGENESIS; INFLAMMATION; INTERMEDIATE UVEITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; RETINA MACULA CYSTOID EDEMA; T LYMPHOCYTE ACTIVATION; TISSUE LEVEL;

ADULT; AQUEOUS HUMOR; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; MACULAR EDEMA; MALE; PROSPECTIVE STUDIES; SLOVENIA; UVEITIS, INTERMEDIATE;

EID: 79960728249     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin 2005; 45:1-13.
2. Curnow SJ, Murray PI. Inflammatory mediators of uveitis: cytokines and chemokines. Curr Opin Ophthalmol 2006; 17:532-7.
3. Van der Lelij A, Rothova A. Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? Br J Ophthalmol 1997; 81:976-9.
4. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140:509-16.
5. Sijssens KM, Rijkers GT, Rothova A, Stilma JS, Schellekens PA, de Boer JH. Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis. Exp Eye Res 2007; 85:443-9.
6. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10:411-52.
7. Suhler EB, Smith JR, Giles TR, Lauer AK, Wertheim MS, Kurz DE, Lim L, Mackensen F, Pickard TD, Rosenbaum JT. Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. Arch Ophthalmol 2009; 127:819-22.
8. Jap A, Chee SP. Immunosuppressive therapy for ocular diseases. Curr Opin Ophthalmol 2008; 19:535-40.
9. Murphy CC, Duncan L, Forrester JV, Dick AD. Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis. Br J Ophthalmol 2004; 88:412-6.
10. Santos Lacomba M, Marcos Martín C, Santos Lacomba M, Marcos Martín C, Gallardo Galera JM, Gómez Vidal MA, Collantes Estévez E, Ramírez Chamond R, Omar M. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 2001; 33:251-5.
11. Akdeniz N, Esrefoglu M. Keles MS, Karakuzu A, Atasoy M. Serum interleukin-2, interleukin-6, tumour necrosis factoralpha and nitric oxide levels in patients with Behçet's disease. Ann Acad Med Singapore 2004; 33:596-9.
12. Yoshimura T, Sonoda KH, Ohguro N, Ohsugi Y, Ishibashi T, Cua DJ, Kobayashi T, Yoshida H, Yoshimura A. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology 2009; 48:347-55.
13. De Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res 1992; 11:581-97.
14. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103:11-24.
15. Nussenblatt RB. Uveitis. Fundamentals and Clinical Practice (3rd ed). Philadelphia, Penn: Elsevier; 2004.
16. Perez VL, Papaliodis GN, Chu D, Anzaar F, Christen W, Foster CS. Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm 2004; 12:193-201.
17. Curnow SJ, Falciani F, Durrani OM, Rauz S, Wallace GR, Salmon M, Cheung CM, Ross EJ, Wloka K, Murray PI. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 2005; 46:4251-9.
18. Santos Lacomba M, Marcos Martín C, Gallardo Galera JM, Collantes Estévez E, Ramírez Chamond R, Omar M, Gomez Vidal A. Aqueous humor and serum interleukin-6 in patients with uveitis. Arch Soc Esp Oftalmol 2001; 76:345-50.
19. Lahmar I, Abou-Bacar A, Abdelrahman T, Kairallah M, Speeg- Schatz C, Bourcier T, Sauer A, Villard O, Pfaff AW, Mousli M, Garweg JG, Candolfi E, Guinard M, Babba H, Ben Yahia S. Cytokine profiles in toxoplasmic and viral uveitis. J Infect Dis 2009; 199:1239-49.
20. Klok AM, Luyendijk L, Zaal MJW, Rothova A, Hack CE, Kijlstra A. Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis. Br J Ophthalmol 1998; 82:871-4.
21. Kramer M, Monselise Y, Bahar I, Cohen Y, Weinberger D, Goldenberg-Cohen N. Serum cytokine levels in active uveitis and remission. Curr Eye Res 2007; 32:669-75.
22. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy. Review of a new approach. Pharmacol Rev 2003; 55:241-69.
23. O'Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally- occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 2004; 114:1372-8.
24. Ongkosuwito JV, Feron EJ, van Doornik CE, Van der Lelij A, Hoyng CB, La Heij EC, Kijlstra A. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci 1998; 39:2659-65.
25. Takase H, Futagami Y, Yoshida T, Mochizuki M, Kamoi K, Sugita S, Imai Y. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci 2006; 47:1557-61.
26. van Kooij B, Rothova A, Rijkers GT, deGroot Mijnes J. Distinct cytokine and chemokine profiles in the aqueous humor of patients with uveitis and cystoid macular edema. Am J Ophthalmol 2006; 142:192-4.
27. Yoshida A, Koide Y, Uchijima M, Yoshida TO. IFN gamma induces IL12 mRNA expression by a murine macrophage cell line, J774. Biochem Biophys Res Commun 1994; 198:857-61.
28. el-Shabrawi Y, Livir-Rallatos C, Christen W, Baltatzis B, Foster CS. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis. Ophthalmology 1998; 105:1659-63.
29. Akpek EK, Maca SM, Christen WG, Foster CS. Elevated vitreous interleukin-10 level is not diagnostic of intraocularcentral nervous system lymphoma. Ophthalmology 1999; 106:2291-5.
30. El-Asrar AMA, Struyfb S, Kangavea D, Al-Obeidana SS, Opdenakkerb G, Geboesch K, Van Damme J. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 2011; 139:177-84.
31. Muhaya M, Calder V, Towler HM, Shaer B, McLauchlan M, Lightman S. Characterization of T cells and cytokines in the aqueous humour (AH) in patients with Fuchs' heterochromic cyclitis (FHC) and idiopathic anterior uveitis (IAU). Clin Exp Immunol 1998; 111:123-8.
32. Ahn JK, Yu HG, Chung H, Park YG. Intraocular cytokine environment in active Behçet uveitis. Am J Ophthalmol 2006; 142:429-34.
33. Xu H, Rizzo LV, Silver PB, Casi RR. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokinedependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol 1997; 178:69-78.
34. Hohki S, Ohguro N, Haruta N, Nakai K, Terabe F, Serada S, Fujimoto M, Nomura S, Kawahata H, Kishimoto T, Naka T. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp Eye Res 2010; 91:162-70.
35. Barnes PJ. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 2007; 119:1055-62.
36. Brennan F, Beech J. Update on cytokines in rheumatoid arthritis. Curr Opin Rheumatol 2007; 19:296-301.